ICPT - Intercept Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts15151515
Avg. Estimate-0.55-0.63-2.130.9
Low estimate-0.72-3.21-4.8-3.16
High estimate-0.33-0.09-0.926.69
Year ago EPS-0.257.86.56-2.13
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts15151616
Avg. Estimate78.74M85.9M327.88M408.18M
Low estimate67.96M79.5M307.36M291.15M
High estimate85M103.5M380.5M682.9M
Year ago sales71.76M77.59M285.71M327.88M
Sales growth (year/est)9.70%10.70%14.80%24.50%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.494.61-0.16-0.65
Actual EPS-0.257.8-0.5-0.77
Difference0.243.19-0.34-0.12
Surprise %49.00%69.20%-212.50%-18.50%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.55-0.63-2.130.9
7 days ago-0.55-0.63-2.130.9
30 days ago-0.52-0.61-2.130.52
60 days ago-0.47-0.55-1.92-0.93
90 days ago-0.46-0.58-1.98-0.91
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 days11N/A1
Up last 30 days1448
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesICPTIndustrySector(s)S&P 500
Current qtr.-120.00%N/AN/AN/A
Next qtr.-108.10%N/AN/AN/A
Current year-132.50%N/AN/AN/A
Next year142.30%N/AN/AN/A
Next 5 years (per annum)-8.89%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A